GEBBIA, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 7.910
AS - Asia 3.902
EU - Europa 2.040
SA - Sud America 1.230
AF - Africa 102
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.187
Nazione #
US - Stati Uniti d'America 7.774
SG - Singapore 1.760
IE - Irlanda 1.059
BR - Brasile 1.016
HK - Hong Kong 950
CN - Cina 421
VN - Vietnam 317
IT - Italia 226
DE - Germania 190
GB - Regno Unito 159
FR - Francia 109
TR - Turchia 98
AR - Argentina 78
IN - India 76
BD - Bangladesh 64
CA - Canada 63
MX - Messico 58
EC - Ecuador 45
FI - Finlandia 41
CH - Svizzera 37
IQ - Iraq 35
NL - Olanda 35
ZA - Sudafrica 35
ID - Indonesia 34
RU - Federazione Russa 30
PL - Polonia 26
MA - Marocco 22
SE - Svezia 22
CO - Colombia 19
ES - Italia 19
JP - Giappone 19
PY - Paraguay 18
VE - Venezuela 18
AT - Austria 16
UA - Ucraina 15
CZ - Repubblica Ceca 14
PK - Pakistan 13
KZ - Kazakistan 12
CL - Cile 10
LT - Lituania 10
SA - Arabia Saudita 10
TN - Tunisia 10
UZ - Uzbekistan 10
PH - Filippine 9
UY - Uruguay 9
BO - Bolivia 8
JO - Giordania 8
PE - Perù 8
AZ - Azerbaigian 7
IL - Israele 7
KR - Corea 7
NP - Nepal 7
DZ - Algeria 6
EG - Egitto 6
KE - Kenya 6
MY - Malesia 6
SN - Senegal 6
AL - Albania 5
LB - Libano 5
AE - Emirati Arabi Uniti 4
BY - Bielorussia 4
BE - Belgio 3
CI - Costa d'Avorio 3
ET - Etiopia 3
KW - Kuwait 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
AM - Armenia 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CR - Costa Rica 2
HN - Honduras 2
IR - Iran 2
KH - Cambogia 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SV - El Salvador 2
TH - Thailandia 2
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
MD - Moldavia 1
MR - Mauritania 1
NO - Norvegia 1
PA - Panama 1
Totale 15.178
Città #
Dallas 3.215
Dublin 1.053
San Jose 1.039
Hong Kong 944
Singapore 920
Ashburn 668
The Dalles 433
Boardman 376
Chicago 360
Santa Clara 346
Ho Chi Minh City 126
Beijing 116
London 98
São Paulo 94
Istanbul 76
Hanoi 66
Los Angeles 64
Assago 56
Munich 54
Rio de Janeiro 39
Milan 38
Zurich 37
Helsinki 36
Frankfurt am Main 33
New York 28
Belo Horizonte 26
Prineville 26
Amsterdam 24
Brooklyn 24
Fort Worth 24
Montreal 24
Chandler 23
Mexico City 23
Johannesburg 21
Warsaw 21
Boston 20
Council Bluffs 19
Quito 19
Brasília 18
San Francisco 18
Tokyo 18
Chennai 17
Curitiba 17
Haiphong 17
Springfield 17
Naples 16
Porto Alegre 16
Atlanta 15
Biên Hòa 15
Catania 15
Guayaquil 15
Hillsboro 15
Phoenix 15
Stockholm 15
Denver 14
Dhaka 14
Baghdad 13
Guarulhos 13
Orem 13
Ottawa 12
Washington 12
Goiânia 10
Seattle 10
Tashkent 10
Berlin 9
Brno 9
Hải Dương 9
New Delhi 9
Shanghai 9
Amman 8
Ankara 8
Asunción 8
Charlotte 8
Düsseldorf 8
Juiz de Fora 8
Manaus 8
Ninh Bình 8
Nuremberg 8
Rome 8
Baku 7
Betim 7
Bogotá 7
Campinas 7
Caracas 7
Fortaleza 7
Guangzhou 7
Limburg an der Lahn 7
Manchester 7
Montevideo 7
Philadelphia 7
Reston 7
Salvador 7
Santo André 7
Thái Nguyên 7
Bauru 6
Campo Grande 6
Can Tho 6
Da Nang 6
Dakar 6
Erbil 6
Totale 11.255
Nome #
112. UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 307
Opsoclonus-myoclonus Syndrome in a Female Breast Cancer Patient: A Case Report and Literature Review 280
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 231
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: A phase II study 187
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin plus etoposide in extensive small-cell lung cancer (SCLC) patients The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial 115
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma? 103
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 95
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 94
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer 92
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group 91
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 90
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 86
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 86
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 85
A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study 85
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma] 84
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 83
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 83
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 81
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer 80
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 80
5-Fluorouracil and Recombinant Alpha Interferon-2a in the Treatment of Advanced Colorectal Carcinoma: a Dose Optimization Study 79
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer 78
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial 78
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group 78
Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis 77
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer 77
5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group 76
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 76
A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinoma 76
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: A whatsapp messenger-based report from the Italian college of chief medical oncologists 75
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations 75
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic Strategy 74
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 74
Brain Metastasis in Endometrial Cancer: A Systematic Review 73
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients' Queries, Needs, Fears, and Actions Taken 72
A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer. 72
A Phase II Study of Levofolinic Acid and 5-Fluorouracil Plus Cisplatin in Patients with Advanced Head and Neck Squamous Cell Carcinoma 71
5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: a phase II randomized trial 71
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients 70
5-fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: Results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.) 68
Gastric metastasis from breast cancer 68
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial 65
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 65
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 64
A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma 64
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 60
TOWARD A NEW PROGNOSTIC-THERAPEUTIC INDEX IN GERIATRIC ONCOLOGY 60
Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy 60
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety 59
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial. 58
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 58
Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study 58
Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603). 58
Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer 57
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 57
Risk-reducing mastectomy in healthy women with BRCA mutation: a narrative review 57
First-line treatment with epirubicin and vinorelbine in metastatic breast cancer 56
In vivo stimulation of murine haematopoiesis by the antineoplastic agent bryostatin-1 55
Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients 55
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study 54
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 54
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 53
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 53
Usefulness of oral medroxyprogesterone acetate in the management of cancer-related cachexia-anorexia syndrome 53
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice 52
Combination Chemotherapy with Cyclophosphamide, Doxorubicin and Vincristine in the Treatment of Stage III-IV Small-Cell Lung Cancer 52
The Effects of the Macrocyclic Lactone Bryostatin-1 on Leukemic Cells in Vitro 52
The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy 52
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 52
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer 52
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer 51
Safety of a 3-weekly schedule of carboplatin pegylate liposomal doxorubicin as first line chemotherapy results in patients with ovarian cancer preliminary results of the MITO-2 randomized trial 51
Breast Cancer in Two Ex-Votos, A Millennia Apart: Patients' Hope and Faith Expressed Through the Centuries in Votive Offerings 51
Gemcitabine Plus Vinorelbine Compared With Cisplatin Plus Vinorelbine or Cisplatin Plus Gemcitabine for Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group 51
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 51
Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma 50
A Phase I—II Study of Cyclophosphamide, Epidoxorubicin, Levofolinic Acid/5-Fluorouracil and Recombinant Human Granulocyte Colony Stimulating Factor in Metastatic Breast Carcinoma 50
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 50
UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 50
Latissimus Dorsi Flap and Thoracodorsal Artery Perforator Flap with Immediate Fat Transfer (LIFT and TIFT): A Retrospective Study about Total Breast Reconstruction in High-Risk Patients 50
Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer 49
Vinblastine and Interferon-Alpha-2a Regimen in the Treatment of Metastatic Renal Cell Carcinoma 49
Alpha interferon in the treatment of hairy cell leukemia 49
The Effectiveness of Combination Chemotherapy with Cisplatinum and Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer 49
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 49
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience 49
Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale 48
Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society of Medical Oncology (AIOM) 48
Nutritional management of the patient with pancreatic cancer: From the diagnostic and therapeutic pathway to an integrated hospital-territory approach 48
Cancer: New needs, new models. is it time for a community oncologist? another brick in the wall 48
Radiofrequency Thermoablation and Hypofractionated Radiotherapy Combined Treatment for Bone Metastases: A Retrospective Study 48
Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells 48
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial 48
Hydroxyurea modulates 5-fluorouracil antineoplastic activity in advanced head and neck carcinoma pretreated with chemotherapy 48
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma 47
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 47
Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB–IV non-small cell lung carcinoma: a prospective randomized study 47
Treatment of refractory metastatic breast cancer with 5-fluorouracil plus levofolinic acid as continuous venous infusion: a phase II study 47
Virtual clinical and precision medicine tumor boards-cloud-based platform-mediated implementation of multidisciplinary reviews among oncology centers in the covid-19 era: Protocol for an observational study 46
Totale 7.138
Categoria #
all - tutte 79.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202226 0 0 0 0 0 0 0 5 2 7 2 10
2022/2023174 13 14 4 8 6 13 3 12 8 3 49 41
2023/2024970 39 84 66 77 138 104 158 62 50 52 40 100
2024/20255.303 423 366 528 100 512 470 409 278 757 561 565 334
2025/20269.096 642 2.102 1.788 836 320 395 1.122 734 756 401 0 0
Totale 15.569